NAVCO Pharmaceuticals Inc. (TSXV:NAV)

Market Cap	285.35K
Revenue (ttm)	n/a
Net Income	-68.84K
EPS	-0.00
Shares Out	57.07M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.0050
Day's Range	n/a
52-Week Range	0.0050 - 0.0100
Beta	2.14
Analysts	n/a
Price Target	n/a
Est. Earnings	Jan 29, 2027

About NAVCO Pharmaceuticals

NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms. NAVCO Pharmaceuticals Inc. is headquar...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Geoffrey Lee
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NAV

Financial Performance

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Oct 9, 2026

Data Sources Report a data error